A Phase II Study of Continuous Infusional 5-Fluorouracil (5-FU) and Subcutaneous Interleukin-2 (IL-2) in Metastatic Renal Cancer

Author： Savage P.   Costelna D.   Moore J.   Gore M.E.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.7, 1997-06, pp. : 1149-1151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Phase II trial of interleukin 2, interferon , and 5-fluorouracil in metastatic renal cell cancer - a cytokine working group study.

By Dutcher J.   Logan T.   Gordon M.   Sosman J.   Weiss G.   Margolin K.   Plasse T.   Mier J.   Lotze M.   Clark J.   Atkins M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-84

Elsevier

Access to resources Recommend Favorite

A Phase II Study of Continuous Infusion 5-Fluorouracil (5-FU) with Epirubicin and Cisplatin in Metastatic, Hormone-resistant Prostate Cancer: an Active New Regimen

By Chao D.   von Schlippe M.   Harland S.J.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1230-1233

Elsevier

Access to resources Recommend Favorite

A Phase III Study of Recombinant Interleukin-2, 5-Fluorouracil and Leucovorin Versus 5-Fluorouracil and Leucovorin in Patients with Unresectable or Metastatic Colorectal Carcinoma

By Heys S.D.   Eremin O.   Ruggeri E.M.   Pein F.   Rainer H.   Oskam R.   de Peuter R.A.   Palmer P.A.   Franks C.R.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 19-25

Elsevier

Access to resources Recommend Favorite

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer

By Duffour Jacqueline   Gourgou Sophie   Desseigne Françoise   Debrigode Charles   Mineur Laurent   Pinguet Frédéric   Poujol Sylvain   Chalbos Patrick   Bressole Françoise   Ychou Marc  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 383-389

Springer Publishing Company

Access to resources Recommend Favorite